Jardiance 25 mg, Filmtabletten - 90 Swissmedic Key 63227004 PP Registration Holder Boehringer Ingelheim (Schweiz) GmbH Name Jardiance 25 mg, Filmtabletten Date of registration 12.11.2014 Introduction of Sequence 10.08.2017 ATC-Classification Empagliflozin (A10BK03) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06.20. Show package size 90 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680632270045 Medication Code Synthetika Pharmacode Disponibility
Composition empagliflozinum 25 mg, lactosum monohydricum 113 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.008 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 400, E 171, E 172 (flavum), pro compresso. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Empagliflozinum 25 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hydroxypropylcellulosum Hypromellosum Überzug Lactose Monohydrate 113 mg Macrogol 400 Magnesii Stearas Pro Compresso Silica Colloidalis Anhydrica Talcum
Source Data was imported : 06.02.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
